the comparison of ECG changes propofole and sevoflurane cochlear implantation

the comparison effect of propofolel and sevoflurane on the QT interval prolongation in pediatrics undergoing cochlear implantation

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017082131487N2

Enrollment

Registered

2017-10-16

Start date

2017-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cochlear implantation. other specified diseases of inner ear(h83.8(

Interventions

Intervention 1: Intervention Group1:2.5mg/kg propofol for induction. Intervention 2: Intervention Group2:sevofeloran with mac 8% for induction.

Treatment - Drugs

Intervention Group1:2.5mg/kg propofol for induction

Intervention Group2:sevofeloran with mac 8% for induction

Eligibility

Sex/Gender

All

Age

6 Months to 18 Years

Inclusion criteria

Inclusion criteria: inclusion critria : patients aged 6 months to 18years condidate for cochlear implantation . exclusion critria: known case of jervell lange nielson syndrome , patients with any cardiac disease, ECG abnormalitie, electrolyte abnormalitie, usage of drags which prolong the QT interval and family history of QT prolongation .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
QT INTERVAL. Timepoint: AFTER THE INDACTION. Method of measurement: ECG MONITORING AND CALCULATED BY THE CARDIOLOGIST.	—

Secondary

Measure	Time frame
PROLONGET TP-E INTERVALL. Timepoint: 5 AND 15 MINIUTE AFTER DRAG ADMINISRATION. Method of measurement: ECG MONITORING AND CALCULATED BY CARDIOLOGIST.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDR.reza safaeeian

rasool akram hospital

rezasafa@yahoo.com+98 21 6435 2326

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026